Answers are grounded in this paper and cite their sources.
Background: Ischemic cerebrovascular conditions lead to brain tissue oxygen depletion, triggering activation and infiltration of inflammatory cells and immunological reactions. Reperfusion induces the release of reactive oxygen species (ROS), triggered by therapeutic recanalization or natural thrombus disintegration. Method: Rats were divided into four groups after a week of acclimatization: Sham group: No occlusion of common carotid arteries after general anesthesia. Ischemic-reperfused control group: General anesthesia, followed by 30 minutes of common carotid artery occlusion and one hour of reperfusion without drugs. Vehicle group: Similar to control group but with intraperitoneal (i.p.) administration of DMSO 30 minutes prior to ischemia. Etanercept group: Identical procedure as control, with additional intraperitoneal (i.p.) administration of etanercept (50 mg/kg) 30 minutes before ischemia. Results: Etanercept groups showed significant reduction in NF-kB and TLRs (2 and 4) compared to control (P<0.05). Histologically, brain tissue lesions were reduced in etanercept groups compared to control and vehicle groups (P<0.05). Conclusion: Etanercept exhibits neuroprotective effect against cerebral I/R injury by down-regulating TNF-α protein and inflammation TLRs.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: